Hadly Baldwin
The financial implications of psychotherapy and the expense of medical care are becoming more significant. The current study looked at the relationship between symptom and cost reduction as well as the pre-post decrease of impairment and direct health care expenses based on therapy termination (regularly ended, dropout with an unproblematic reason, and dropout with a quality-relevant reason). Using the Patient Health Questionnaire, several conditions were evaluated: depression, anxiety, stress, and somatization (PHQ). Health insurances covered the following expenses on an annual basis: inpatient costs, outpatient costs, medicine costs, hospital days, work disability days, psychotherapy use, and pharmacotherapy use 1 year before therapy and 1 year after therapy. Partially correlated data and hierarchical linear models were used to analyse the relationships between symptom and cost reduction. Each of the three groups had a decrease in medical expenses and symptoms. Not every dropout might be viewed as a therapy failure, according to the average symptom and cost decrease of patients with a quality-relevant dropout.